NYT New York Times Co. : Bullish and Bearish Analyst Opinions

Bearish on NYT due to deteriorating fundamental metrics (slowing subscriber growth, rising churn) and significant insider selling, which signal underlying business weakness.

The speaker explicitly named the New York Times, Washington Post, and Wall Street Journal, stating their circulations are "way down" because people don't believe them anymore due to publishing "fake" and "bad" stories, leading to a loss of credibility. A sustained loss of public trust and declining circulation directly threatens the advertising revenue and subscription business models of these legacy media companies. The speaker's direct attack links falling circulation to a fundamental credibility crisis, presenting a bearish fundamental case. These publications may retain a dedicated subscriber base or pivot their business model successfully.

Suggests accumulating a position in NYT to gain board influence and correct perceived media bias.

The author promotes their own analysis over a New York Times article without providing specific financial data.

The @nytimes is not a newspaper. It is a propaganda machine.

The New York Times is cited as the counter-example to the newspaper collapse because "they adapted" and became a "gaming company" and lifestyle bundle rather than just a newspaper. In a market panicked about disruption, capital flows to companies that have successfully navigated a pivot. NYT represents the "survivor" archetype—a legacy business that successfully monetized the new paradigm. Long. It serves as a quality hedge against the broader disruption theme. General media sector weakness or consumer spending slowdowns.

"Is the New York Times still a newspaper company? Like absolutely not... It made sure that it wasn't the thing that was being disrupted... That's what, for example, like a Figma is doing... partnering with an Anthropic." Survival in a disruption cycle requires a radical pivot. NYT survived the internet by becoming a gaming/recipe bundle. Software companies must pivot from being "tools for humans" to "platforms for AI" (like Figma's partnership with Anthropic) to survive. Watch for software companies announcing deep, structural partnerships with AI model providers (like Anthropic) or pivoting revenue models. These are the potential long-term winners emerging from the sell-off. Pivots are difficult to execute and capital intensive; many legacy firms will fail to make the transition.

The stock is positioned to appreciate further due to significant accumulation by institutional investors at key price levels, suggesting strong underlying support.

"This is the kind of moment where you don't just do a sharp intake of breath... people are standing up at their desk just wanting to make eye contact and talk about the enormity of what's happened." This is a massive global attention event ("uncharted territory"). News corporations, particularly those with strong tabloid arms (News Corp) or investigative prestige (NYT, mentioned in transcript regarding "Icelandic material"), will see a significant spike in engagement, ad revenue, and subscriptions due to the "PR nightmare" and public interest. LONG. A tactical trade on the "attention economy" spike surrounding the trial and investigation. The news cycle is short; engagement bumps are often transient and may not materially impact quarterly earnings if the story fades quickly.

13F filings reveal Berkshire Hathaway built a new stake in The New York Times (NYT) while simultaneously cutting its Amazon (AMZN) position by 75%. Berkshire’s move into NYT suggests a value play on legacy media durability or cash flow, while the massive reduction in AMZN signals a belief that the capital is better deployed elsewhere (likely cash/T-bills given their $380B cash pile) or that AMZN is fully valued relative to growth prospects. Follow the "Smart Money" rotation: Long NYT, Trim/Short AMZN. These are lagging indicators (Q4 data); Berkshire may have already exited or adjusted further.

Berkshire Hathaway bought shares in The New York Times, AstraZeneca, and Occidental Petroleum. This represents a classic defensive rotation: Media (subscription stability), Healthcare (drug demand independent of economy), and Energy (inflation hedge). LONG NYT, AZN, OXY. Sector-specific regulatory risks (drug pricing for AZN, oil prices for OXY).